{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:09:04Z","timestamp":1789024144045,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004913","name":"Universit\u00e0 degli Studi di Palermo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004913","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is increasingly conceptualised as a biological and clinical continuum that includes Subjective cognitive decline (SCD), mild cognitive impairment (MCI), and overt dementia. We conducted a systematic review and meta-analysis to assess the prevalence of APOE \u03b54 allele in individuals with SCD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods\/aims<\/jats:title>\n                    <jats:p>\n                      Main databases were searched to identify studies published up to 15 April 2026, plus citation checking. Eligible studies included participants with SCD defined according to standardized criteria, with available APOE genotype data. Application of SCD-\n                      <jats:italic>plus<\/jats:italic>\n                      criteria was also recorded.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 474 screened records, 49 studies were included in the quantitative synthesis. The pooled prevalence of APOE \u03b54 allele carriers was 28.3% (95% CI 25.1\u201331.8%) in SCD, 41.0% (95% CI 35.3\u201346.8%) in MCI, and 22.0% (95% CI 18.6\u201325.9%) in cognitively normal (CN) individuals. Multivariate analysis showed that the odds of being an APOE \u03b54 allele carrier were significantly higher in SCD compared to HC (OR = 1.28, 95% CI 1.12\u20131.46,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001) and higher in MCI compared to SCD (OR = 1.48, 95% CI 1.23\u20131.76,\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.0001). Meta-regression analyses indicated that age and education contributed to heterogeneity in SCD cohorts, while sex distribution did not. Sensitivity analyses restricted to SCD-\n                      <jats:italic>plus<\/jats:italic>\n                      studies confirmed the robustness of these findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The prevalence of APOE \u03b54 allele in SCD falls between that observed in CN and MCI populations, supporting its role as an intermediate stage in the AD continuum. However, substantial heterogeneity persists, highlighting the need for more accurate stratification approaches integrating genetic and clinical markers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-026-14077-5","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T10:50:13Z","timestamp":1788087013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["APOE in subjective cognitive decline: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"273","author":[{"given":"Paolo","family":"Alonge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovico","family":"Baiamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gerardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Lo Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Labate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2829-523X","authenticated-orcid":false,"given":"Roberto","family":"Monastero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"issue":"10513","key":"14077_CR1","first-page":"1873","volume":"406","author":"GBD 2023 Disease and Injury and Risk Factor Collaborators","year":"2023","unstructured":"GBD 2023 Disease and Injury and Risk Factor Collaborators (2023) Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406(10513):1873\u20131922","journal-title":"Lancet"},{"key":"14077_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111821","volume":"212","author":"A Nicoletti","year":"2023","unstructured":"Nicoletti A, Baschi R, Cicero CE, Iacono S, Re VL, Luca A et al (2023) Sex and gender differences in Alzheimer\u2019s disease, Parkinson\u2019s disease, and Amyotrophic Lateral Sclerosis: a narrative review. Mech Ageing Dev 212:111821","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"14077_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.12779\/dnd.2017.16.2.40","volume":"16","author":"YJ Hong","year":"2017","unstructured":"Hong YJ, Lee JH (2017) Subjective cognitive decline and Alzheimer\u2019s disease spectrum disorder. Dement Neurocogn Disord 16(2):40\u201347","journal-title":"Dement Neurocogn Disord"},{"issue":"8","key":"14077_CR4","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s Dementia 20(8):5143\u20135169","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"6","key":"14077_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G et al (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 10(6):844\u201352","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"2","key":"14077_CR6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2009.01.015","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2023) Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimer\u2019s Dementia: Trans Res Clin Intervent 9(2):e12385","journal-title":"Alzheimer\u2019s Dementia: Trans Res Clin Intervent"},{"issue":"4","key":"14077_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.14283\/jpad.2023.114","volume":"10","author":"M Barbera","year":"2023","unstructured":"Barbera M, Perera D, Matton A, Mangialasche F, Rosenberg A, Middleton L et al (2023) Multimodal precision prevention\u2014a new direction in Alzheimer\u2019s disease. J Prev Alzheimers Dis 10(4):718\u2013728","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"14077_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13195-020-00699-y","volume":"12","author":"TM Liew","year":"2020","unstructured":"Liew TM (2020) Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia. Alzheimers Res Ther 12(1):135","journal-title":"Alzheimers Res Ther"},{"key":"14077_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2023.104629","volume":"149","author":"R An","year":"2024","unstructured":"An R, Gao Y, Huang X, Yang Y, Yang C, Wan Q (2024) Predictors of progression from subjective cognitive decline to objective cognitive impairment: a systematic review and meta-analysis of longitudinal studies. Int J Nurs Stud 149:104629","journal-title":"Int J Nurs Stud"},{"issue":"20","key":"14077_CR10","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH et al (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90(20):9649\u20139653","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"14077_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang YA, Zhou B, Wernig M, S\u00fcdhof TC (2017) ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion. Cell 168(3):427\u2013441","journal-title":"Cell"},{"issue":"9","key":"14077_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G (2019) Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15(9):501\u2013518","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"14077_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JAD-180248","volume":"65","author":"JI Ali","year":"2018","unstructured":"Ali JI, Smart CM, Gawryluk JR (2018) Subjective cognitive decline and APOE \u03b54: a systematic review. J Alzheimer\u2019s Dis 65(1):303\u2013320","journal-title":"J Alzheimer\u2019s Dis"},{"key":"14077_CR14","doi-asserted-by":"crossref","unstructured":"Morgan RL, Whaley P, Thayer KA, Sch\u00fcnemann HJ (2018) Identifying the PECO: a framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Environment International, vol 121. Elsevier Ltd, pp 1027\u201331","DOI":"10.1016\/j.envint.2018.07.015"},{"key":"14077_CR15","volume":"372","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"2","key":"14077_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1017\/S1041610292000991","volume":"4","author":"TH Crook","year":"1992","unstructured":"Crook TH, Feher EP, Larrabee GJ (1992) Assessment of memory complaint in age-associated memory impairment: the MAC-Q. Int Psychogeriatr 4(2):165\u2013176","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"14077_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/JAD-132027","volume":"41","author":"L Rami","year":"2014","unstructured":"Rami L, Mollica MA, Garcfa-Sanchez C, Saldafia J, Sanchez B, Sala I et al (2014) The subjective cognitive decline questionnaire (SCD-Q): a validation study. J Alzheimer\u2019s Dis 41(2):453\u2013466","journal-title":"J Alzheimer\u2019s Dis"},{"key":"14077_CR18","doi-asserted-by":"crossref","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C (2020) Chapter 5: systematic reviews of prevalence and incidence. In: Aromataris E, Munn Z (eds) JBI Manual for Evidence Synthesis. JBI","DOI":"10.46658\/JBIRM-17-05"},{"issue":"10","key":"14077_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JAC Sterne","year":"2001","unstructured":"Sterne JAC, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54(10):1046\u201355. https:\/\/doi.org\/10.1016\/S0895-4356(01)00377-8","journal-title":"J Clin Epidemiol"},{"key":"14077_CR20","unstructured":"RsT (2019) RStudio: Integrated Development for R. RStudio, Inc., Boston, MA. http:\/\/www.rstudio.com"},{"key":"14077_CR21","unstructured":"Team RC (2021) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org"},{"issue":"3","key":"14077_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1\u201348","journal-title":"J Stat Softw"},{"issue":"29","key":"14077_CR23","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1002\/sim.8362","volume":"38","author":"F Sera","year":"2019","unstructured":"Sera F, Armstrong B, Blangiardo M, Gasparrini A (2019) An extended mixed-effects framework for meta-analysis. Stat Med 38(29):5429\u20135444. https:\/\/doi.org\/10.1002\/sim.8362","journal-title":"Stat Med"},{"key":"14077_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.829031","volume":"16","author":"L Hao","year":"2022","unstructured":"Hao L, Jia J, Xing Y, Han Y (2022) APOE \u03b54 allele distribution and association with scores of subjective cognitive decline questionnaire 9 in a large Chinese memory clinic cohort. Front Neurosci 16:829031","journal-title":"Front Neurosci"},{"key":"14077_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.686036","volume":"12","author":"K Hestad","year":"2021","unstructured":"Hestad K, Engedal K, Horndalsveen P, Strand BH (2021) Cognition in patients with memory difficulties and dementia relative to APOE e4 status. Front Psychol 12:686036","journal-title":"Front Psychol"},{"issue":"1","key":"14077_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13195-018-0444-1","volume":"10","author":"I de Rojas","year":"2018","unstructured":"de Rojas I, Romero J, Rodr\u00edguez-Gomez O, Pesini P, Sanabria A, P\u00e9rez-Cordon A et al (2018) Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundaci\u00f3 ACE Healthy Brain Initiative (FACEHBI). Alzheimers Res Ther 10(1):119","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"14077_CR27","doi-asserted-by":"publisher","first-page":"fcaf078","DOI":"10.1093\/braincomms\/fcaf078","volume":"7","author":"V Alanko","year":"2025","unstructured":"Alanko V, Mravinacov\u00e1 S, Hall A, Hagman G, Mohanty R, Westman E et al (2025) Biological signatures in the Alzheimer\u2019s continuum discriminate between diagnosis-related and -unrelated associations to ATN categories. Brain Commun 7(2):fcaf078","journal-title":"Brain Commun"},{"issue":"16","key":"14077_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164735","volume":"13","author":"M Baquero","year":"2024","unstructured":"Baquero M, Ferr\u00e9-Gonz\u00e1lez L, \u00c1lvarez-S\u00e1nchez L, Ferrer-Cairols I, Garc\u00eda-Vall\u00e9s L, Peret\u00f3 M et al (2024) Insights from a 7-year dementia cohort (VALCODIS): ApoE genotype evaluation. J Clin Med 13(16):4735","journal-title":"J Clin Med"},{"issue":"2","key":"14077_CR29","volume":"16","author":"L Bl\u00f6meke","year":"2024","unstructured":"Bl\u00f6meke L, Rehn F, Kraemer-Schulien V, Kutzsche J, Pils M, Bujnicki T et al (2024) A\u03b2 oligomers peak in early stages of Alzheimer\u2019s disease preceding tau pathology. Alzheimer\u2019s Dementia: Diagn, Assess Dis Monit 16(2):e12589","journal-title":"Alzheimer\u2019s Dementia: Diagn, Assess Dis Monit"},{"key":"14077_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1389595","volume":"16","author":"CH Hsieh","year":"2024","unstructured":"Hsieh CH, Ko CA, Liang CS, Yeh PK, Tsai CK, Tsai CL et al (2024) Longitudinal assessment of plasma biomarkers for early detection of cognitive changes in subjective cognitive decline. Front Aging Neurosci 16:1389595","journal-title":"Front Aging Neurosci"},{"key":"14077_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100924","volume":"43","author":"R Yu","year":"2024","unstructured":"Yu R, Kong SD, Ireland C, Steiner-Lim GZ, Bassett K, Almgren H et al (2024) Associations of high-sensitivity C-reactive protein with neuropsychological outcomes and cerebral white matter hyperintensities in older adults at risk of dementia. Brain Behav Immun Health 43:100924","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"14077_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13195-023-01273-y","volume":"15","author":"YJ Hong","year":"2023","unstructured":"Hong YJ, Ho S, Jeong JH, Park KH, Kim S, Wang MJ et al (2023) Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study. Alzheimers Res Ther 15(1):132","journal-title":"Alzheimers Res Ther"},{"key":"14077_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101904","volume":"198","author":"S Ayton","year":"2021","unstructured":"Ayton S, Janelidze S, Roberts B, Palmqvist S, Kalinowski P, Diouf I et al (2021) Acute phase markers in CSF reveal inflammatory changes in Alzheimer\u2019s disease that intersect with pathology, APOE \u03b54, sex and age. Prog Neurobiol 198:101904","journal-title":"Prog Neurobiol"},{"issue":"10","key":"14077_CR34","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/acn3.51153","volume":"7","author":"H Hu","year":"2020","unstructured":"Hu H, Tan L, Bi YL, Xu W, Tan L, Shen XN et al (2020) Association of serum Apolipoprotein B with cerebrospinal fluid biomarkers of Alzheimer\u2019s pathology. Ann Clin Transl Neurol 7(10):1766\u20131778","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"14077_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3233\/JAD-160176","volume":"54","author":"M Mandecka","year":"2016","unstructured":"Mandecka M, Budziszewska M, Barczak A, Pep\u0142o\u0144ska B, Chodakowska-\u017bebrowska M, Filipek-Gliszczy\u0144ska A et al (2016) Association between cerebrospinal fluid biomarkers for Alzheimer\u2019s disease, APOE genotypes and auditory verbal learning task in subjective cognitive decline, mild cognitive impairment, and Alzheimer\u2019s disease. J Alzheimers Dis 54(1):157\u2013168","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"14077_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100331","volume":"13","author":"M Zurr\u00f3n","year":"2025","unstructured":"Zurr\u00f3n M, Pereiro AX, Rodriguez-Perez AI, Galdo-\u00c1lvarez S, Ansede JJ, Lojo-Seoane C et al (2025) Plasma and neurostructural biomarkers in the clinical-biological characterization of early stages of the Alzheimer\u2019s disease continuum: findings from the Compostela Aging Study. J Prev Alzheimers Dis 13(1):100331","journal-title":"J Prev Alzheimers Dis"},{"issue":"9","key":"14077_CR37","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1002\/alz.14094","volume":"20","author":"HW Roh","year":"2024","unstructured":"Roh HW, Chauhan N, Seo SW, Choi SH, Kim EJ, Cho SH et al (2024) Assessing cognitive impairment and disability in older adults through the lens of whole brain white matter patterns. Alzheimer\u2019s Dementia 20(9):6032\u20136044","journal-title":"Alzheimer\u2019s Dementia"},{"key":"14077_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neurobiolaging.2023.06.014","volume":"130","author":"CG Swinford","year":"2023","unstructured":"Swinford CG, Risacher SL, Vosmeier A, Deardorff R, Chumin EJ, Dzemidzic M et al (2023) Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer\u2019s disease. Neurobiol Aging 130:103\u2013113","journal-title":"Neurobiol Aging"},{"issue":"3","key":"14077_CR39","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3233\/JAD-230131","volume":"94","author":"M Caillaud","year":"2023","unstructured":"Caillaud M, Maltezos S, Hudon C, Mellah S, Belleville S (2023) Hippocampal volume and episodic associative memory identify memory risk in subjective cognitive decline individuals in the CIMA-Q cohort, regardless of cognitive reserve level and APOE4 status. J Alzheimers Dis 94(3):1047\u20131056","journal-title":"J Alzheimers Dis"},{"key":"14077_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.806032","volume":"14","author":"B Zhou","year":"2022","unstructured":"Zhou B, Wu X, Tang L, Li C (2022) Dynamics of the brain functional network associated with subjective cognitive decline and its relationship to apolipoprotein E \u03b54 alleles. Front Aging Neurosci 14:806032","journal-title":"Front Aging Neurosci"},{"key":"14077_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.646017","volume":"13","author":"Q Chen","year":"2021","unstructured":"Chen Q, Lu J, Zhang X, Sun Y, Chen W, Li X et al (2021) Alterations in dynamic functional connectivity in individuals with subjective cognitive decline. Front Aging Neurosci 13:646017","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"14077_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.14283\/jpad.2023.49","volume":"10","author":"L Cui","year":"2023","unstructured":"Cui L, Huang L, Pan FF, Wang Y, Huang Q, Guan YH, Lo CZ, Guo YH, Chan AS, Xie F, Guo Q (2023) Chinese Preclinical Alzheimer's Disease Study (C-PAS): Design and Challenge from PET Acceptance. J Prev Alzheimers Dis 10(3):571\u2013580 https:\/\/doi.org\/10.14283\/jpad.2023.49","journal-title":"J Prev Alzheimers Dis"},{"issue":"18","key":"14077_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13185447","volume":"13","author":"DM Cammisuli","year":"2024","unstructured":"Cammisuli DM, Bellocchio V, Milesi A, Aiello EN, Poletti B, Verde F et al (2024) Behavioral alterations of spatial cognition and role of the Apolipoprotein E-\u03b54 in patients with MCI due to Alzheimer\u2019s disease: results from the BDSC-MCI project. J Clin Med 13(18):5447","journal-title":"J Clin Med"},{"issue":"10","key":"14077_CR44","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/alz.12512","volume":"18","author":"O Janssen","year":"2022","unstructured":"Janssen O, Jansen WJ, Vos SJB, Boada M, Parnetti L, Gabryelewicz T et al (2022) Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimer\u2019s Dementia 18(10):1832\u20131845","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"2","key":"14077_CR45","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3233\/JAD-190601","volume":"73","author":"B Yoon","year":"2020","unstructured":"Yoon B, Choi SH, Jeong JH, Park KW, Kim EJ, Hwang J et al (2020) Balance and mobility performance along the Alzheimer\u2019s disease spectrum. J Alzheimers Dis 73(2):633\u2013644","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"14077_CR46","doi-asserted-by":"publisher","first-page":"e2531038","DOI":"10.1001\/jamanetworkopen.2025.31038","volume":"8","author":"F M\u00e1rquez","year":"2025","unstructured":"M\u00e1rquez F, Tarraf W, Gonzalez K, Valencia DF, Stickel AM, Anita NZ et al (2025) Alzheimer disease biomarkers and subjective cognitive decline among Hispanic and\/or Latino adults. JAMA Netw Open 8(9):e2531038","journal-title":"JAMA Netw Open"},{"key":"14077_CR47","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fmed.2020.00298","volume":"7","author":"JS Lee","year":"2020","unstructured":"Lee JS, Soh Y, Kim HG, Lee KM, Kwon YN, Yoon SS et al (2020) Interactive effects of apolipoprotein E \u03b54 and triiodothyronine on memory performance in patients with subjective cognitive decline. Front Med (Lausanne) 7:298","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"14077_CR48","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3233\/JAD-170039","volume":"60","author":"BLR Reijs","year":"2017","unstructured":"Reijs BLR, Vos SJB, Soininen H, L\u00f6tjonen J, Koikkalainen J, Pikkarainen M et al (2017) Association between later life lifestyle factors and Alzheimer\u2019s disease biomarkers in non-demented individuals: a longitudinal descriptive cohort study. J Alzheimers Dis 60(4):1387\u20131395","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"14077_CR49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/00019442-200508000-00013","volume":"13","author":"NT Lautenschlager","year":"2005","unstructured":"Lautenschlager NT, Flicker L, Vasikaran S, Leedman P, Almeida OP (2005) Subjective memory complaints with and without objective memory impairment: relationship with risk factors for dementia. Am J Geriatr Psychiatry 13(8):731\u2013734","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"14077_CR50","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1007\/s11357-024-01069-4","volume":"46","author":"C Morrison","year":"2024","unstructured":"Morrison C, Oliver MD, Berry V, Kamal F, Dadar M (2024) The influence of APOE status on rate of cognitive decline. Geroscience 46(3):3263\u20133274","journal-title":"Geroscience"},{"key":"14077_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neurobiolaging.2017.04.002","volume":"57","author":"AC van Harten","year":"2017","unstructured":"van Harten AC, Jongbloed W, Teunissen CE, Scheltens P, Veerhuis R, van der Flier WM (2017) CSF ApoE predicts clinical progression in nondemented APOE\u03b54 carriers. Neurobiol Aging 57:186\u201394","journal-title":"Neurobiol Aging"},{"issue":"4","key":"14077_CR52","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.3233\/JAD-221280","volume":"93","author":"S Xu","year":"2023","unstructured":"Xu S, Ren Y, Liu R, Li Y, Hou T, Wang Y et al (2023) Prevalence and progression of subjective cognitive decline among rural Chinese older adults: a population-based study. J Alzheimers Dis 93(4):1355\u20131368","journal-title":"J Alzheimers Dis"},{"key":"14077_CR53","volume":"17","author":"G Giacomucci","year":"2025","unstructured":"Giacomucci G, Moschini V, Ceccarelli A et al (2025) Gender differences in cognitive reserve: an impact on progression in subjective cognitive decline? Alzheimer\u2019s Dementia 17:e70174","journal-title":"Alzheimer\u2019s Dementia"},{"key":"14077_CR54","doi-asserted-by":"publisher","first-page":"e64853","DOI":"10.2196\/64853","volume":"13","author":"B Kang","year":"2025","unstructured":"Kang B, Hong D, Yoon S, Kang C, Kim JI (2025) Assessing social interaction and loneliness and their association with frailty among older adults with subjective cognitive decline or mild cognitive impairment: ecological momentary assessment approach. JMIR Mhealth Uhealth 13:e64853","journal-title":"JMIR Mhealth Uhealth"},{"issue":"3","key":"14077_CR55","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3233\/JAD-160407","volume":"54","author":"S Wolfsgruber","year":"2016","unstructured":"Wolfsgruber S, Kleineidam L, Wagner M, M\u00f6sch E, Bickel H, L\u00fchmann D et al (2016) Differential risk of incident Alzheimer\u2019s disease dementia in stable versus unstable patterns of subjective cognitive decline. J Alzheimer\u2019s Dis 54(3):1135\u20131146","journal-title":"J Alzheimer\u2019s Dis"},{"key":"14077_CR56","first-page":"221","volume":"11","author":"D M\u00fcller-Gerards","year":"2019","unstructured":"M\u00fcller-Gerards D, Weimar C, Abramowski J, Tebr\u00fcgge S, Jokisch M, Dragano N et al (2019) Subjective cognitive decline, APOE \u03b54, and incident mild cognitive impairment in men and women. Alzheimer\u2019s Dementia: Diagn, Assess Dis Monit 11:221\u2013230","journal-title":"Alzheimer\u2019s Dementia: Diagn, Assess Dis Monit"},{"issue":"2","key":"14077_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.14283\/jpad.2023.12","volume":"10","author":"AKW Lee","year":"2023","unstructured":"Lee AKW, Collier MK, Thompson LI, Popescu D, Arthur E, Correia S et al (2023) The effects of subjective cognitive decline on APOE genotype disclosure in the Butler Hospital Alzheimer\u2019s Prevention Registry. J Prev Alzheimers Dis 10(2):152\u2013161","journal-title":"J Prev Alzheimers Dis"},{"issue":"6","key":"14077_CR58","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/08919887241237224","volume":"37","author":"DL Popescu","year":"2024","unstructured":"Popescu DL, Lee AK, Arthur E, Thompson LI, Alber J (2024) APOE genotype disclosure influences decisions about future planning but not adoption of healthy lifestyle changes in cognitively unimpaired individuals. J Geriatr Psychiatry Neurol 37(6):482\u2013495","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"14077_CR59","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13195-024-01458-z","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu Z, Shi D, Cai Y, Li A, Lan G, Sun P et al (2024) Pathophysiology characterization of Alzheimer\u2019s disease in South China\u2019s aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS). Alzheimers Res Ther 16(1):84","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"14077_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/03036758.2022.2098780","volume":"53","author":"LJ Tippett","year":"2022","unstructured":"Tippett LJ, Cawston EE, Morgan CA, Melzer TR, Brickell KL, Ilse C et al (2022) Dementia prevention research clinic: a longitudinal study investigating factors influencing the development of Alzheimer\u2019s disease in Aotearoa, New Zealand. J R Soc N Z 53(4):489\u2013510","journal-title":"J R Soc N Z"},{"issue":"5","key":"14077_CR61","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/ene.14167","volume":"27","author":"S Mazzeo","year":"2020","unstructured":"Mazzeo S, Padiglioni S, Bagnoli S, Carraro M, Piaceri I, Bracco L et al (2020) Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer\u2019s disease: an 11-year follow-up study. Eur J Neurol 27(5):894\u2013899","journal-title":"Eur J Neurol"},{"issue":"1","key":"14077_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00704-4","volume":"12","author":"F Baldacci","year":"2020","unstructured":"Baldacci F, Lista S, Manca ML, Chiesa PA, Cavedo E, Lemercier P et al (2020) Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study. Alzheimers Res Ther 12(1):147","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"14077_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00738-8","volume":"12","author":"J Stockmann","year":"2020","unstructured":"Stockmann J, Verberk IMW, Timmesfeld N, Denz R, Budde B, Lange-Leifhelm J et al (2020) Amyloid-\u03b2 misfolding as a plasma biomarker indicates risk for future clinical Alzheimer\u2019s disease in individuals with subjective cognitive decline. Alzheimers Res Ther 12(1):169","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"14077_CR64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","volume":"17","author":"B Dubois","year":"2018","unstructured":"Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O et al (2018) Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of Alzheimer\u2019s disease (INSIGHT-preAD): a longitudinal observational study. Lancet Neurol 17(4):335\u2013346","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"14077_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000439258","volume":"16","author":"A Sierra-Rio","year":"2016","unstructured":"Sierra-Rio A, Balasa M, Olives J, Antonell A, Iranzo A, Castellv\u00ed M et al (2016) Cerebrospinal fluid biomarkers predict clinical evolution in patients with subjective cognitive decline and mild cognitive impairment. Neurodegener Dis 16(1\u20132):69\u201376","journal-title":"Neurodegener Dis"},{"issue":"15","key":"14077_CR66","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1212\/WNL.0000000000000856","volume":"83","author":"RJ Kryscio","year":"2014","unstructured":"Kryscio RJ, Abner EL, Cooper GE, Fardo DW, Jicha GA, Nelson PT et al (2014) Self-reported memory complaints: implications from a longitudinal cohort with autopsies. Neurology 83(15):1359\u20131365","journal-title":"Neurology"},{"issue":"1","key":"14077_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01566-w","volume":"16","author":"V Jurasova","year":"2024","unstructured":"Jurasova V, Andel R, Katonova A, Veverova K, Zuntychova T, Horakova H et al (2024) CSF neurogranin levels as a biomarker in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a cross-sectional analysis. Alzheimers Res Ther 16(1):199","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"14077_CR68","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3233\/JAD-170231","volume":"60","author":"T Fladby","year":"2017","unstructured":"Fladby T, P\u00e5lhaugen L, Selnes P, Waterloo K, Br\u00e5then G, Hessen E et al (2017) Detecting at-risk Alzheimer\u2019s disease cases. J Alzheimers Dis 60(1):97\u2013105","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"14077_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20(1):68\u201380","journal-title":"Lancet Neurol"},{"issue":"8","key":"14077_CR70","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tem.2023.05.002","volume":"34","author":"LG Yang","year":"2023","unstructured":"Yang LG, March ZM, Stephenson RA, Narayan PS (2023) Apolipoprotein E in lipid metabolism and neurodegenerative disease. Trends Endocrinol Metab 34(8):430\u2013445","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"14077_CR71","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"TV Huynh","year":"2017","unstructured":"Huynh TV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H et al (2017) Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron 96(5):1013\u20131023","journal-title":"Neuron"},{"key":"14077_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1412006","volume":"16","author":"KE Foley","year":"2024","unstructured":"Foley KE, Wilcock DM (2024) Three major effects of APOE\u03b54 on A\u03b2 immunotherapy induced ARIA. Front Aging Neurosci 16:1412006","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"14077_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC (2022) ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):72","journal-title":"Mol Neurodegener"},{"issue":"10","key":"14077_CR74","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1136\/jnnp.2010.231555","volume":"82","author":"LS Elias-Sonnenschein","year":"2011","unstructured":"Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ (2011) Predictive value of APOE-\u03b54 allele for progression from MCI to AD-type dementia: a meta-analysis. J Neurol Neurosurg Psychiatry 82(10):1149\u20131156","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"14077_CR75","first-page":"2289","volume":"27","author":"V Bessi","year":"2020","unstructured":"Bessi V, Mazzeo S, Padiglioni S, Bagnoli S, Nacmias B, Sorbi S et al (2020) PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10-year follow-up study. Eur J Neurol 27(11):2289\u20132297","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14077-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14077-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14077-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:04:06Z","timestamp":1789023846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-14077-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["14077"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14077-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,30]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"556"}}